DrugJan 18, 2023
Northern VA Compounders PLLC QuadMix Standard 002 recall — FDA D-0104-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 79
10,685 detailed records are currently available in this category.
DrugJan 18, 2023
Northern VA Compounders PLLC TriMix Injection recall — FDA D-0114-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC TriMix Injection recall — FDA D-0113-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC BiMix Injection recall — FDA D-0122-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC TriMix Plus 001 recall — FDA D-0117-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC QuadMix Standard 001 recall — FDA D-0107-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC QuadMix Super 001 recall — FDA D-0105-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Rifampin Capsules USP, 300 mg, 30-count bottle recall — FDA D-0100-2023
Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugJan 18, 2023
Northern VA Compounders PLLC Prostaglandin (E1) Injection Solution, 10 mcg/ml recall — FDA D-0109-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 11, 2023
Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride recall — FDA D-0097-2023
Lack of assurance of sterility: Bags have the potential to leak.
Class IIFDA: CompletedPfizer Inc.
DrugJan 11, 2023
Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL) recall — FDA D-0095-2023
Presence of Particulate Matter: Customer complaint of dark particles found inside the vial
Class IIFDA: OngoingEugia US LLC
DrugJan 4, 2023
NCH Life Sciences Alcohol Antiseptic 80% Topical Solution Hand Sanitizer, Non-Sterile recall — FDA D-0092-2023
CGMP Deviations: Impurities of acetal and acetaldehyde were discovered in the product in excess of allowed limits.
Class IIFDA: CompletedNCH Life Sciences LLC
DrugJan 4, 2023
Ganciclovir for Injection, USP, 500mg per vial recall — FDA D-0090-2023
Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.
Class IIFDA: TerminatedHikma Pharmaceuticals USA Inc.
DrugJan 4, 2023
Apotex Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL recall — FDA D-0093-2023
Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.
Class IIIFDA: TerminatedApotex Corp.
DrugDec 28, 2022
Quinapril Tablets USP, 20 mg (90 pack) recall — FDA D-0089-2023
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugDec 28, 2022
Oxcarbazepine Tablets 600mg recall — FDA D-0085-2023
Presence of foreign substance
Class IIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugDec 28, 2022
Quinapril Tablets USP, 40 mg (90 pack) recall — FDA D-0088-2023
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugDec 21, 2022
Lacosamide Oral Solution, USP, CV, 10mg/mL recall — FDA D-0094-2023
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
Class IIIFDA: TerminatedCamber Pharmaceuticals, Inc.
DrugDec 21, 2022
Exela Pharma Sciences 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL recall — FDA D-0080-2023
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Class IFDA: TerminatedExela Pharma Sciences LLC
DrugDec 21, 2022
SODIUM BICARBONATE 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL recall — FDA D-0079-2023
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Class IFDA: TerminatedExela Pharma Sciences LLC
DrugDec 21, 2022
BayCare Integrated Service Center, LLC /dba Iohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml recall — FDA D-0086-2023
Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL
Class IFDA: TerminatedBayCare Integrated Service Center, LLC /dba BayCare…
DrugDec 14, 2022
SODIUM CHLORIDE 0.9% Sodium Chloride Injection, USP, Each 100 mL contains: SODIUM CHLORIDE recall — FDA D-0075-2023
Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.
Class IIFDA: OngoingFresenius Medical Care Holdings, Inc.
DrugDec 14, 2022
RemedyRepack Desmopressin Acetate Tablet, 0.2 mg, 100-count box recall — FDA D-0077-2023
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Class IIFDA: TerminatedRemedyRepack Inc.
DrugDec 7, 2022
Acella Pharmaceuticals Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g recall — FDA D-0074-2023
Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
Class IIIFDA: TerminatedAcella Pharmaceuticals, LLC
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.